A Consensus Statement for Continuous Glucose Monitoring Metrics for Inpatient Clinical Trials

Author:

Spanakis Elias K.1ORCID,Cook Curtiss B.2ORCID,Kulasa Kristen3ORCID,Aloi Joseph A.4ORCID,Bally Lia5ORCID,Davis Georgia6ORCID,Dungan Kathleen M.7ORCID,Galindo Rodolfo J.8ORCID,Mendez Carlos E.9ORCID,Pasquel Francisco J.6ORCID,Shah Viral N.10ORCID,Umpierrez Guillermo E.6ORCID,Aaron Rachel E.11ORCID,Tian Tiffany11ORCID,Yeung Andrea M.11ORCID,Huang Jingtong11ORCID,Klonoff David C.12ORCID

Affiliation:

1. Baltimore VA Medical Center, University of Maryland School of Medicine, Baltimore, MD, USA

2. Division of Endocrinology, Mayo Clinic Arizona, Scottsdale, AZ, USA

3. Division of Endocrinology and Metabolism, Department of Medicine, University of California, San Diego, La Jolla, CA, USA

4. Atrium Health Wake Forest Baptist, Winston-Salem, NC, USA

5. Department of Diabetes, Endocrinology, Nutritional Medicine and Metabolism, Inselspital, Bern University Hospital and University of Bern, Bern, Switzerland

6. Emory University School of Medicine, Atlanta, GA, USA

7. Division of Endocrinology, Diabetes & Metabolism, The Ohio State University, Columbus, OH, USA

8. Miller School of Medicine, University of Miami, Miami, FL, USA

9. Medical College of Wisconsin, Milwaukee, WI, USA

10. Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus, Aurora, CO, USA

11. Diabetes Technology Society, Burlingame, CA, USA

12. Diabetes Research Institute, Mills-Peninsula Medical Center, San Mateo, CA, USA

Abstract

Diabetes Technology Society organized an expert consensus panel to develop metrics for research in the use of continuous glucose monitors (CGMs) in a hospital setting. The experts met virtually in small groups both before and after an April 13, 2023 virtual meeting of the entire panel. The goal of the panel was to develop consensus definitions in anticipation of greater use of CGMs in hospital settings in the future. Establishment of consensus definitions of inpatient analytical metrics will be easier to compare outcomes between studies. Panelists defined terms related to 10 dimensions of measurements related to the use of CGMs including (1) hospital hypoglycemia, (2) hospital hyperglycemia, (3) hospital time in range, (4) hospital glycemic variability, (5) hospital glycemia risk index, (6) accuracy of CGM devices and reference methods for CGMs in the hospital, (7) meaningful time blocks for hospital glycemic goals, (8) hospital CGM data sufficiency, (9) using CGM data for insulin dosing, and (10) miscellaneous factors. The panelists voted on 51 proposed recommendations. Based on the panel vote, 51 recommendations were classified as either strong (43) or mild (8). Additional research is needed on CGM performance in the hospital. This consensus report is intended to support that type of research intended to improve outcomes for hospitalized people with diabetes.

Funder

Diabetes Technology Society

Publisher

SAGE Publications

Subject

Biomedical Engineering,Bioengineering,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference105 articles.

1. Abbott’s FreeStyle® Libre 14 day system now available in U.S. for hospitalized patients with diabetes during COVID-19 pandemic. Abbott Mediaroom. https://abbott.mediaroom.com/2020-04-08-Abbotts-FreeStyle-R-Libre-14-Day-System-Now-Available-in-U-S-for-Hospitalized-Patients-with-Diabetes-During-COVID-19-Pandemic. Accessed May 16, 2023.

2. Dexcom CGM. Temporarily available in hospitals during COVID-19 emergency. Dexcom. https://www.dexcom.com/en-us/news/dexcom-cgm-hospital-covid19. Accessed May 16, 2023.

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3